Personalized diagnosis for rare kidney diseases
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have protein or blood in your urine that is not explained by a kidney biopsy or has not gotten better with standard treatments like steroids.
- You have a family history of kidney disease or your parents were related by blood.
- You have health problems outside the kidney that may be linked to a rare disease.
- An ultrasound showed you have at least two cysts in each kidney, or your kidneys appear brighter than normal, or you have calcium deposits in the kidneys.
- You have a long-term acid or base imbalance in your blood, or abnormal calcium or phosphate levels that are not due to another known cause.
- You are willing to share your medical information and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at ways to predict how kidney disease may develop, change, or cause complications using information from patients. It may help doctors identify people at higher risk and tailor care earlier.
This trial studies kidney biopsy samples to learn how certain kidney cells repair damage. It may help find new treatments for kidney diseases.
This study aims to improve how doctors diagnose nephrotic syndrome by using a personalized workflow. If you have nephrotic syndrome and are under 40 years old, this trial might help find the best treatment for your specific type.
This study creates a registry to collect health information from people with rare kidney diseases. It aims to improve understanding and future treatments by tracking patient experiences.
This study tests whether people with chronic kidney disease (CKD) should get genetic testing right away to find potential inherited causes. It aims to help patients and their families understand their kidney condition better and guide treatment decisions.
This study uses genetic testing to look for inherited (“monogenic”) reasons some people get kidney stones. It may help explain the cause of stones and calcium-related problems, which can guide future care for you or your family.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.